Skip to main content

Guidance Documents

1272 Results
Guidance Documents

Civil Unrest Q&A Offsite Dosing Option

Question and answer concerning off-site dosing of narcotic treatment program patients during civil unrest.

ID: DEA-DC-036
Component Diversion Control Program (DEA)
Date Issued: June 9, 2020
Guidance Documents

Civil Unrest Q&A Pharmacy move CS without Address Change

Question and answer concerning moving controlled substances to another address without changing the address of the DEA registered location.

ID: DEA-DC-034
Component Diversion Control Program (DEA)
Date Issued: June 7, 2020
Guidance Documents

Civil Unrest Q&A Suspicious Order Reporting

Question and Answer concerning suspicious order reporting during the civil unrest and looting.

ID: DEA-DC-035
Component Diversion Control Program (DEA)
Date Issued: June 6, 2020
Guidance Documents

Civil Unrest Q&A Theft and Loss

Question and answer concerning reporting of theft and/or loss of controlled substances during civil unrest and looting.

ID: DEA-DC-33
Component Diversion Control Program (DEA)
Date Issued: June 5, 2020
Guidance Documents

COVID-19 Office Site Delivery Buprenorphine

During the COVID-19 health emergency, DEA will permit OTPs to regularly use off-site locations located in the same state in which they are registered with DEA to deliver take-home doses of buprenorphine to patients authorized to receive them, without separately registering those locations.  OTPs must obtain approval for unregistered delivery locations from local DEA offices and SOTA.

ID: DEA-DC-030
Component Diversion Control Program (DEA)
Date Issued: April 28, 2020
Guidance Documents

COVID-19 Exception (5% Rule)

During the Covid19 Public Health Emergency, DEA will temporarily permit registered practitioners such as hospitals, pharmacies, and physicians to distribute controlled substances (CS) in excess of five percent of their total number of dosage units of CS distributed to other registered dispensers during this calendar year, without registering as a distributor.  All DEA security, recordkeeping and other applicable regulations, including state requirements, remain in effect.

ID: DEA-DC-029
Component Diversion Control Program (DEA)
Date Issued: April 13, 2020
Guidance Documents

COVID-19 OTP Signed Delivery Exception to Regs

During the Covid-19 Public Health Emergency, DEA will permit distributors to deliver narcotic substances to Narcotic Treatment Programs without requiring immediate signature by the NTP’s authorized individual accepting delivery.  Distributors must confirm physical possession by the NTP and complete additional recordkeeping requirements in a timely manner.

ID: DEA-DC-027
Component Diversion Control Program (DEA)
Date Issued: April 11, 2020